Exhibit 10.1

HEALTH CATALYST, INC.

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

The purpose of this Non-Employee Director Compensation Policy (the “Policy”) of
Health Catalyst, Inc., a Delaware corporation (the “Company”), is to provide a
total compensation package that enables the Company to attract and retain, on a
long-term basis, high-caliber directors who are not employees or officers of the
Company or its subsidiaries (“Outside Directors”). This Policy will become
effective as of the effective time of the registration statement for the
Company’s initial public offering of equity securities (the “Effective Date”).
In furtherance of the purpose stated above, all Outside Directors shall be paid
compensation for services provided to the Company as set forth below:
I.
Cash Retainers

(a)Annual Retainer for Board Membership: $35,000 for general availability and
participation in meetings and conference calls of our Board of Directors. No
additional compensation for attending individual Board meetings.

(b)Additional Annual Retainers for Committee Membership:

Audit Committee Chairperson:                        $20,000
Audit Committee member:                             $10,000
Compensation Committee Chairperson:                     $10,000
Compensation Committee member:                         $5,000
Nominating and Corporate Governance Committee Chairperson:         $7,500
Nominating and Corporate Governance Committee member:         $3,750
(c)Additional Retainer for Non-Executive Chairman of the Board: $30,000 to
acknowledge the additional responsibilities and time commitment of the role.

II.
Equity Retainers

All grants of equity retainer awards to Outside Directors pursuant to this
Policy will be automatic and nondiscretionary and will be made in accordance
with the following provisions:
(a)    Value. For purposes of this Policy, “Value” means with respect to (i) any
award of stock options the grant date fair value of the option (i.e.,
Black-Scholes Value) determined in accordance with the reasonable assumptions
and methodologies employed by the Company for calculating the fair value of
options under ASC 718; and (ii) any award of restricted stock and restricted
stock units the product of (A) the average closing market price on the NASDAQ
(or such other market on which the Company’s Common Stock is then principally
listed) of one share of the Company’s Common Stock over the trailing 30-day
period ending on the last day of the month immediately prior to the month of the
grant date or if the Company’s Common Stock has been listed and traded for less
than 30 days prior to the month of the grant date, then the average

--------------------------------------------------------------------------------

closing market price on the NASDAQ (or such other market on which the Company’s
Common Stock is then principally listed) of one share of the Company’s Common
Stock over the total trailing period ending on the day immediately prior to the
grant date and (B) the aggregate number of shares pursuant to such award.

(b)    Revisions. Subject to approval from the Board of Directors, the
Compensation Committee in its discretion may change and otherwise revise the
terms of awards to be granted under this Policy, including, without limitation,
the number of shares subject thereto, for awards of the same or different type
granted on or after the date the Compensation Committee determines to make any
such change or revision.

(c)    Sale Event Acceleration. In the event of a Sale Event (as defined in the
Company’s 2019 Stock Option and Incentive Plan (the “2019 Plan”)), the equity
retainer awards granted to Outside Directors pursuant to this Policy shall
become 100% vested and exercisable.

(d)    Initial Grant. Upon initial election to the Board of Directors, each new
Outside Director will receive an initial, one-time grant of restricted stock
units (the “Initial Grant”) with a Value of $225,000 that vests in three equal
annual installments over three years; provided, however, that all vesting ceases
if the director resigns from our Board of Directors or otherwise ceases to serve
as a director, unless the Board of Directors determines that the circumstances
warrant continuation of vesting. This Initial Grant applies to Outside Directors
who are first elected to the Board of Directors effective as of or subsequent to
the Company’s initial public offering.

(e)    Annual Grant. On the date of the Company’s Annual Meeting of
Stockholders, each Outside Director who will continue as a member of the Board
of Directors following such Annual Meeting of Stockholders will receive a grant
of restricted stock units on the date of such Annual Meeting (the “Annual
Grant”) with a Value of $150,000 that vests in full on the earlier of (i) the
one-year anniversary of the grant date or (ii) the next Annual Meeting of
Stockholders; provided, however, that all vesting ceases if the director resigns
from our Board of Directors or otherwise ceases to serve as a director, unless
the Board of Directors determines that the circumstances warrant continuation of
vesting.

III.
Expenses

The Company will reimburse all reasonable out-of-pocket expenses incurred by
Outside Directors in attending meetings of the Board of Directors or any
Committee thereof.
IV.
Maximum Annual Compensation

The aggregate amount of compensation, including both equity compensation and
cash compensation, paid to any Outside Director in a calendar year period shall
not exceed (i) $1,000,000 in the first calendar year an individual becomes an
Outside Director and (ii) $500,000 in any other year (or in each case, such
other limits as may be set forth in Section 3(b) of the 2019 Plan or any similar
provision of a successor plan). For this purpose, the “amount” of equity
compensation paid in a calendar year shall be determined based on the grant date
fair value thereof, as determined in accordance with ASC 718 or its successor
provision, but excluding the impact of estimated forfeitures related to
service-based vesting conditions.

Date Policy Approved: June 27, 2019